Juan A. Vara-Oramas

Av. Monforte De Lemos 5
Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy.

Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy.

Journal: Cancer immunology, immunotherapy : CII
Published: February 02, 2026

Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.

Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.

Journal: Metabolomics : Official journal of the Metabolomic Society
Published: February 24, 2023

Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.

Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.

Journal: BMC cancer
Published: August 26, 2019

Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.

Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.

Journal: BMC cancer
Published: April 22, 2019

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.

Journal: Scientific reports
Published: June 11, 2018

Melanoma proteomics suggests functional differences related to mutational status.

Melanoma proteomics suggests functional differences related to mutational status.

Journal: Scientific reports
Published: February 12, 2018

Functional proteomics outlines the complexity of breast cancer molecular subtypes.

Functional proteomics outlines the complexity of breast cancer molecular subtypes.

Journal: Scientific reports
Published: April 04, 2017

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications.

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications.

Journal: Cancer research
Published: July 03, 2014
Showing 1-8 of 8

Last Updated: 09/26/2026